Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Brain Disorders

imatinib mesylate has been researched along with Brain Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Insabato, L; Montella, L; Palmieri, G1
Altundag, K; Altundag, MB; Altundag, O; Boruban, C; Yavas, O1
Huang, M; Liu, WL; Ran, D; Sun, HY; Zhang, YC; Zhou, JF1
Bown, N; Kalra, S; Nath, U; Neylon, AJ; Wilkins, BS; Williams, C; Wilson, V1

Other Studies

4 other study(ies) available for imatinib mesylate and Brain Disorders

ArticleYear
Imatinib mesylate for cerebral Langerhans'-cell histiocytosis.
    The New England journal of medicine, 2004, Sep-02, Volume: 351, Issue:10

    Topics: Adult; Benzamides; Brain Diseases; Enzyme Inhibitors; Female; Histiocytosis, Langerhans-Cell; Humans; Imatinib Mesylate; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Skin

2004
Imatinib may be useful in the management of patients with glioblastoma.
    Medical hypotheses, 2005, Volume: 65, Issue:6

    Topics: Antineoplastic Agents; Benzamides; Brain Diseases; Clinical Trials as Topic; Evidence-Based Medicine; Glioblastoma; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Radiation-Sensitizing Agents

2005
[Ph+ acute lymphoblastic leukemia combined with lung and brain invasive aspergillosis].
    Zhongguo shi yan xue ye xue za zhi, 2006, Volume: 14, Issue:3

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Benzamides; Brain Diseases; Humans; Imatinib Mesylate; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines

2006
FIP1L1-PDGFRA positive chronic eosinophilic leukaemia and associated central nervous system involvement.
    Journal of clinical pathology, 2008, Volume: 61, Issue:5

    Topics: Benzamides; Brain Diseases; Female; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Magnetic Resonance Imaging; Middle Aged; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha

2008